BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11251382)

  • 1. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA.
    Manam S; Ledwith BJ; Barnum AB; Troilo PJ; Pauley CJ; Harper LB; Griffiths TG; Niu Z; Denisova L; Follmer TT; Pacchione SJ; Wang Z; Beare CM; Bagdon WJ; Nichols WW
    Intervirology; 2000; 43(4-6):273-81. PubMed ID: 11251382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice.
    Ledwith BJ; Manam S; Troilo PJ; Barnum AB; Pauley CJ; Griffiths TG; Harper LB; Beare CM; Bagdon WJ; Nichols WW
    Intervirology; 2000; 43(4-6):258-72. PubMed ID: 11251381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z; Soleimanjahi H; Mirshahabi H; Meshkat M; Kheirandish M; Hassan ZM
    Iran J Immunol; 2011 Jun; 8(2):65-75. PubMed ID: 21705833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA vaccines: assay for integration into host genomic DNA.
    Ledwith BJ; Manam S; Troilo PJ; Barnum AB; Pauley CJ; Griffiths TG; Harper LB; Schock HB; Zhang H; Faris JE; Way PA; Beare CM; Bagdon WJ; Nichols WW
    Dev Biol (Basel); 2000; 104():33-43. PubMed ID: 11713822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts.
    Sheets RL; Stein J; Manetz TS; Duffy C; Nason M; Andrews C; Kong WP; Nabel GJ; Gomez PL
    Toxicol Sci; 2006 Jun; 91(2):610-9. PubMed ID: 16569729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of DNA vaccine potency using conventional aluminum adjuvants.
    Ulmer JB; DeWitt CM; Chastain M; Friedman A; Donnelly JJ; McClements WL; Caulfield MJ; Bohannon KE; Volkin DB; Evans RK
    Vaccine; 1999 Aug; 18(1-2):18-28. PubMed ID: 10501231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.
    Bråve A; Gudmundsdotter L; Sandström E; Haller BK; Hallengärd D; Maltais AK; King AD; Stout RR; Blomberg P; Höglund U; Hejdeman B; Biberfeld G; Wahren B
    Vaccine; 2010 Nov; 28(51):8203-9. PubMed ID: 20951666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants.
    Ohlschläger P; Quetting M; Alvarez G; Dürst M; Gissmann L; Kaufmann AM
    Int J Cancer; 2009 Jul; 125(1):189-98. PubMed ID: 19358269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution of a plasmid DNA containing epitopes of foot-and-mouth disease virus in mice.
    Zhang HY; Sun SH; Guo YJ; Chen ZH; Huang L; Gao YJ; Wan B; Zhu WJ; Xu GX; Wang JJ
    Vaccine; 2005 Dec; 23(48-49):5632-40. PubMed ID: 16125283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.
    Lasaro MO; Diniz MO; Reyes-Sandoval A; Ertl HC; Ferreira LC
    Microbes Infect; 2005 Dec; 7(15):1541-50. PubMed ID: 16213178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys.
    Raviprakash K; Ewing D; Simmons M; Porter KR; Jones TR; Hayes CG; Stout R; Murphy GS
    Virology; 2003 Oct; 315(2):345-52. PubMed ID: 14585337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancement of a hepatitis B DNA vaccine potency using aluminum phosphate in mice].
    Liang ZW; Ren H; Lang YH; Li YG
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):79-81. PubMed ID: 14980105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenicity of N-protein of Puumala hantavirus for noninbred mice in the intramuscular administration of its gene DNA].
    Chubukova OV; Khasanova SS; Nikonorov IuM; Kulagin VF; Chemeris AV; Vakhitov VA
    Vopr Virusol; 2008; 53(4):38-41. PubMed ID: 18756816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts.
    Sheets RL; Stein J; Manetz TS; Andrews C; Bailer R; Rathmann J; Gomez PL
    Toxicol Sci; 2006 Jun; 91(2):620-30. PubMed ID: 16569728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Collection of Plasmid DNA in Large and Growing Animal Muscles 6 Weeks after DNA Vaccination with and without Electroporation.
    Dory D; Le Moigne V; Cariolet R; Béven V; Keranflec'h A; Jestin A
    J Immunol Res; 2015; 2015():326825. PubMed ID: 26380318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model.
    Imoto J; Konishi E
    Viral Immunol; 2005; 18(1):205-12. PubMed ID: 15802965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA immunization--a new chance in vaccine research?
    Henke A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):187-90. PubMed ID: 12458358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.